Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Repellin, Claire E ^a   Tsimbouri, Penelope M ^a   Philbey, Adrian W ^b   Wilson, Joanna B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ENCODED SMALL RNA EBER1; IMMUNOGLOBULIN HEAVY CHAIN; INITIATION FACTOR 2ALPHA; PROTEIN KINASE R; UNCLASSIFIED DRUG; UNTRANSLATED RNA; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 1; MYC PROTEIN; MYC PROTEIN, MOUSE; OLIGONUCLEOTIDE; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; LIVER; LYMPH NODE; LYMPHOID HYPERPLASIA; LYMPHOMA; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PROTEIN PHOSPHORYLATION; SPLEEN; THYMUS; ANIMAL; FEMALE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HYPERPLASIA; LYMPHOID TISSUE; MALE; METABOLISM; PATHOLOGY; PEYER PATCH; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSGENIC MOUSE; WESTERN BLOTTING;

HUMAN HERPESVIRUS 4; MUS; MUS MUSCULUS;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; HYPERPLASIA; LYMPHOID TISSUE; LYMPHOMA, B-CELL; MALE; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDES; PEYER'S PATCHES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; T-LYMPHOCYTES; THYMUS GLAND;

EID: 77949413439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009092     Document Type: Article

References (44)

1. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768.
2. Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, et al. (2008) EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68: 1436-1442.
3. Rosa MD, Gottlieb E, Lerner MR, Steitz JA (1981) Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1: 785-796.
4. Arrand JR, Young LS, Tugwood JD (1989) Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J Virol 63: 983-986.
5. Howe JG, Shu MD (1989) Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements. Cell 57: 825-834.
6. Glickman JN, Howe JG, Steitz JA (1988) Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol 62: 902-911.
7. Howe JG, Shu MD (1988) Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs. J Virol 62: 2790-2798.
8. Lu CC, Wu CW, Chang SC, Chen TY, Hu CR, et al. (2004) Epstein-Barr virus nuclear antigen 1 is a DNA-binding protein with strong RNA-binding activity. J Gen Virol 85: 2755-2765.
9. Clemens MJ (2006) Epstein-Barr virus: Inhibition of apoptosis as a mechanism of cell transformation. Int J Biochem Cell Biol 38: 164-169.
10. Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K (2006) EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. Embo J 25: 4207-4214.
11. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K (2002) Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J 21: 954-965.
12. Ruf IK, Lackey KA, Warudkar S, Sample JT (2005) Protection from Interferon-Induced Apoptosis by Epstein-Barr Virus Small RNAs Is Not Mediated by Inhibition of PKR. J Virol 79: 14562-14569.
13. Fok V, Friend K, Steitz JA (2006) Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling. J Cell Biol 173: 319-325.
14. Lerner MR, Andrews NC, Miller G, Steitz JA (1981) Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 78: 805-809.
15. Khan G, Coates PJ, Kangro HO, Slavin G (1992) Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes. J Clin Pathol 45: 616-620.
16. Yamamoto N, Takizawa T, Iwanaga Y, Shimizu N (2000) Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs. FEBS Lett 484: 153-158.
17. Komano J, Maruo S, Kurozumi K, Oda T, Takada K (1999) Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 73: 9827-9831.
18. Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT (2000) Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol 74: 10223-10228.
19. Yajima M, Kanda T, Takada K (2005) Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth Transformation. J Virol 79: 4298-4307.
20. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, et al. (2000) Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. Embo J 19: 6742-6750.
21. Yang L, Aozasa K, Oshimi K, Takada K (2004) Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res 64: 5332-5337.
22. Iwakiri D, Sheen TS, Chen JY, Huang DP, Takada K (2005) Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 24: 1767-1773.
23. Wu Y, Maruo S, Yajima M, Kanda T, Takada K (2007) Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J Virol 81: 11236-11245.
24. Eilebrecht S, Pellay FX, Odenwalder P, Brysbaert G, Benecke BJ, et al. (2008) EBER2 RNA-induced transcriptome changes identify cellular processes likely targeted during Epstein Barr Virus infection. BMC Res Notes 1: 100.
25. Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, et al. (2003) The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med Sci Monit 9: HY1-9.
26. Paule MR, White RJ (2000) Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Res 28: 1283-1298.
27. Arrand JR, Rymo L (1982) Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J Virol 41: 376-389.
28. Jat P, Arrand JR (1982) In vitro transcription of two Epstein-Barr virus specified small RNA molecules. Nucleic Acids Res 10: 3407-3425.
29. Sharp TV, Schwemmle M, Jeffrey I, Laing K, Mellor H, et al. (1993) Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res 21: 4483-4490.
30. Laing KG, Elia A, Jeffrey I, Matys V, Tilleray VJ, et al. (2002) In vivo effects of the Epstein-Barr virus small RNA EBER-1 on protein synthesis and cell growth regulation. Virology 297: 253-269.
31. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, et al. (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533-538.
32. Dildrop R, Ma A, Zimmerman K, Hsu E, Tesfaye A, et al. (1989) IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. EMBO J 8: 1121-1128.
33. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N (1992) Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257: 1685-1689.
34. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG (1993) Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A 90: 232-236.
35. Ma L, Weinberg RA (2008) MicroRNAs in malignant progression. Cell Cycle 7: 570-572.
36. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, et al. (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E{micro}-miR155 transgenic mice. Proc Natl Acad Sci U S A 103: 7024-7029.
37. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
38. Grundhoff A, Sullivan CS, Ganem D (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. Rna 12: 733-750.
39. Grey F, Hook L, Nelson J (2008) The functions of herpesvirus-encoded microRNAs. Med Microbiol Immunol 197: 261-267.
40. Sano M, Kato Y, Taira K (2006) Sequence-specific interference by small RNAs derived from adenovirus VAI RNA. FEBS Lett 580: 1553-1564.
41. Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61: 1315-1327.
42. Wilson JB, Bell JL, Levine AJ (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 15: 3117-3126.
43. Stevenson D, Charalambous C, Wilson JB (2005) Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGFa Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9. Cancer Res 65: 8826-8835.
44. Charalambous CT, Hannigan A, Tsimbouri P, McPhee GM, Wilson JB (2007) Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF alpha prior to neoplasia. Carcinogenesis 28: 1839-1848.